Free · 13,587 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Oral & Dental

Acceptance and perceived efficacy of intraoral versus extraoral photobiomodulation for oral mucositis prevention in pediatric patients

EO-PBMT demonstrated greater caregiver acceptance and lower treatment-related discomfort than IO-PBMT.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors surveyed caregivers of 32 pediatric oncology patients who received both intraoral and extraoral photobiomodulation for oral mucositis prevention during different chemotherapy cycles. Extraoral treatment was preferred by 65.6% and reported discomfort was lower, while intraoral treatment was more often perceived to give better pain control, a perception the authors note did not match differences in clinical mucositis occurrence or severity.

Participants
32
Who or what was studied
Caregivers of 32 pediatric patients undergoing chemotherapy
Limits stated in the abstract
The study relies on descriptive caregiver questionnaire responses from a small sample, and perceived efficacy did not correspond to clinical differences in mucositis.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Objective

To compare acceptance, tolerability, and perceived efficacy of extraoral (EO) and intraoral (IO) photobiomodulation therapy (PBMT) for oral mucositis (OM) prevention in pediatric oncology patients.

Methods

Caregivers of 32 pediatric patients undergoing chemotherapy completed a structured questionnaire after their children experienced both intraoral and extraoral PBMT for oral mucositis prevention during different chemotherapy cycles within a randomized clinical study. Device preference, discomfort, perceived pain control, and reasons for preference were descriptively analyzed.

Results

EO-PBMT was preferred by 65.6% of respondents, whereas 34.4% preferred IO-PBMT. Preference for EO-PBMT was mainly associated with greater comfort and avoidance of mouth opening. Discomfort was reported by 43.8% during IO-PBM and by 6.3% during EO-PBMT, with a statistically significant difference between the modalities (p = 0.001). IO-PBMT was more often perceived to provide better pain control (34.4%), whereas 12.5% favored EO-PBMT.

Conclusion

EO-PBMT demonstrated greater caregiver acceptance and lower treatment-related discomfort than IO-PBMT. Although caregivers more frequently perceived IO-PBMT as providing better pain control, these subjective perceptions did not correspond to differences in the clinical occurrence or severity of OM between treatment modalities. EO-PBMT therefore represents a feasible and well-accepted approach for supportive care in pediatric oncology.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Oral & Dental

Photobiomodulation for the treatment and prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: a systematic review and meta-analysis of randomized clinical trials published in the last six years

Evidence from recent randomized clinical trials confirms that PBMT is highly effective for the management of oral mucositis, reducing its incidence and severity, improving quality of life and treatment adherence, and potentially lowering healthcare costs during cancer therapy.

Review · May 7, 2026 · G R et al.